Piper Jaffray analyst, Sean Wieland, reiterated his Overweight rating on Imprivata (NYSE: IMPR) but cut his PT by $1 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE